Nuclear antigen histone H1 is primarily involved in lupus erythematosus cell formation

Arthritis and Rheumatism

Volumn 41, Issue 8, 1998, Pages 1446-1455

  Schett, Georg ^a   Steiner, Günter ^a   Smolen, Josef S ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; HISTONE H1;

ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; LUPUS ERYTHEMATOSUS CELL TEST; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIGENS, NUCLEAR; AUTOANTIBODIES; AUTOANTIGENS; FEMALE; HISTONES; HUMANS; IMMUNOBLOTTING; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PRECIPITIN TESTS;

EID: 0031830477     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199808)41:8<1446::AID-ART15>3.0.CO;2-6     Document Type: Article

References (48)

1. Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements: the "tart" cell and the "LE" cell. Mayo Clin Proc 1948;23:25-8.
2. Rifkind RA, Godman GC. Phase contrast and interferometric microscopy of the L.E. cell phenomenon. J Exp Med 1957;106: 607-16.
3. Haserick JR, Lewis LA, Bortz DW. Blood-factor in acute systemic lupus erythematosus. I. Determination of gamma globulin as specific plasma fraction. Am J Med Sci 1950;219:660-3.
4. Aisenberg AC. Studies on the mechanism of the lupus erythematosus (L.E.) phenomenon. J Clin Invest 1959;38:325-33.
5. Holman HR, Deicher HRG, Kunkel HG. The L.E. cell and the L.E. serum factors. Bull N Y Acad Sci 1959;35:409-18.
6. Holman HR, Kunkel HG. Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science 1957;126:162-3.
7. Holman H, Deicher HR. The reaction of the lupus erythematosus (L.E.) cell factor with deoxyribonucleoprotein of the cell nucleus. J Clin Invest 1959;38:2059-72.
8. Robbins WC, Holman HR, Deicher H, Kunkel HG. Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol N Y 1957;96:575-9.
9. Mellors RC, Ortega LG, Holman HR. Role of gamma globulins in the pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction. J Exp Med 1957;106: 191-8.
10. Deicher HRG, Holman HR, Kunkel HG. The precipitin reaction between DNA and a serum factor in systemic lupus erythematosus. J Exp Med 1959;109:97-114.
11. Tan EM, Kunkel HG. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 1966;96:464-71.
12. Von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic disease. Semin Arthritis Rheum 1995;24:323-58.
13. Reeves WH. Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera. J Exp Med 1985;161:18-39.
14. Rekvig OP, Hannestad K. Lupus erythematosus (LE) factors recognize both nucleosomes and viable human leucocytes. Scand J Immunol 1981;13:597-604.
15. Hannestad K, Rekvig OP, Husebekk A. Cross-reacting rheumatoid factors and lupus erythematosus (LE) factors. Springer Semin Immunopathol 1981;4:133-60.
16. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
17. Hassfeld W, Steiner G, Hartmuth K, Kolarz G, Scherak O, Graninger W, et al. Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum 1989;32:1515-20.
18. Lantz ML, Holmes LH. Improved non-radioactive cell surface labeling technique for immunoprecipitation. Biotechniques 1995; 18:58-60.
19. Dubois EL. Simplified method for the L.E. cell test: results of a three year study of seven hundred tests in many disease states. Arch Intern Med 1953;92:168-73.
20. Lachmann PJ. A two stage indirect L.E. cell test. Immunology 1961;4:142-50.
21. Kunkel HG, Holman HR, Deicher HRG. Multiple "autoantibodies" to cell constituents in systemic lupus erythematosus. Ciba Found Symp 1960;8:429-37.
22. Fritzler MJ, Tan EM. Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin Invest 1978;62:560-7.
23. Tan EM. An immunologic precipitin system between soluble nucleoprotein and serum antibody in systemic lupus erythematosus. J Clin Invest 1967;46:735-45.
24. Cohen MG, Pollard KM, Webb J. Antibodies to histones in systemic lupus erythematosus: prevalence, specificity, and relationship to clinical and laboratory features. Ann Rheum Dis 1992;51:61-6.
25. Rubin RL, Bell SA, Burlingame RW. Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. J Clin Invest 1992;90:165-73.
26. Krippner H, Springer B, Merle S, Pirlet K. Antibodies to histones of the IgG and IgM class in systemic lupus erythematosus. Clin Exp Immunol 1984;58:49-56.
27. Weiss RS, Swift S. The significance of a positive LE cell phenomenon. Am Med Assoc Arch Dermatol 1955;72:103-9.
28. McDuffie FC, Blondin C, Golden HE. Immunologic factors in lupus erythematosus cell formation. Mayo Clin Proc 1969;44: 620-9.
29. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
30. Friou GJ. Identification of the nuclear component of the interaction of lupus erythematosus globulin and nuclei. J Immunol 1958;80:476-81.
31. Gioud M, Ait Kaci M, Monier JC. Histone antibodies in systemic lupus erythematosus: a possible diagnostic tool. Arthritis Rheum 1982;25:407-13.
32. Vila JL, Juarez C, Illa I, Agusti M, Gelpi C, Amengual MJ, et al. Autoantibodies against the H10 subtype of histone H1. Clin Immunol Immunopathol 1987;45:499-503.
33. Sato S, Ihn H, Kikuchi K, Takehara K. Antihistone antibodies in systemic sclerosis: association with pulmonary fibrosis. Arthritis Rheum 1994;37:391-4.
34. Pauls JD, Silverman S, Laxer RM, Fritzler MJ. Antibodies to histones H1 and H5 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum 1989;32:877-83.
35. Beck JS, Anderson JR, Gray KG, Rawell NR. Antinuclear and precipitating autoantibodies in progressive systemic sclerosis. Lancet 1963;II:1188-90.
36. Goslings J. Clinical investigation on L.E. cell phenomenon in patients with a rheumatoid arthritis syndrome. Acta Med Scand 1958;341:83-8.
37. Joske RA, King WE. The L.E. cell phenomenon in active chronic viral hepatitis. Lancet 1955;II:477-80.
38. Ogryzlo MA. The L.E. cell reaction. Can Med Assoc J 1956;75: 780-6.
39. Mongey A-B, Donovan-Brand R, Thomas TJ, Adams LE, Hess EV. Serologic evaluation of patients receiving procainamide. Arthritis Rheum 1992;35:219-23.
40. Craft JE, Radding JA, Harding MW, Bernstein RM, Hardin JA. Autoantigenic histone epitopes: a comparison between procainamide- and hydralazine-induced lupus. Arthritis Rheum 1987;30:689-94.
41. Erickson JG, Hines EA, Pease GL, Brunstig LA. Rheumatoid and lupus erythematosus-like syndromes. Arch Dermatol 1956;74:640-50.
42. Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994;94:184-92.
43. Costa O, Tchouatcha-Tchouassom JC, Roux B, Monier JC. Anti-histone antibodies in systemic lupus erythematosus: epitope localization after immunoblotting of chymotrypsin-digested H1. Clin Exp Immunol 1986;63:608-13.
44. Portanova JP, Arndt RE, Tan EM, Kotzin BL. Anti-histone antibodies in idiopathic and drug induced lupus recognize distinct intrahistone regions. J Immunol 1987;138:446-51.
45. Hardin JA, Thomas JO. Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B. Proc Natl Acad Sci U S A 1983;80:7410-4.
46. Gohill J, Cary PD, Couppez CM, Fritzler MJ. Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone. J Immunol 1985;135:3116-21.
47. Wesierska-Gadek J, Penner E, Lindner H, Hitchman E, Sauermann G. Autoantibodies against different histone H1 subtypes in systemic lupus erythematosus sera. Arthritis Rheum 1990;33: 1273-8.
48. Cole RD. A minireview of microheterogeneity in H1 histone and its possible significance. Anal Biochem 1984;136:24-30.